These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21112206)

  • 1. Survival of the fittest: metabolic adaptations in cancer.
    Berardi MJ; Fantin VR
    Curr Opin Genet Dev; 2011 Feb; 21(1):59-66. PubMed ID: 21112206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
    Gatenby RA; Gawlinski ET
    Cancer Res; 2003 Jul; 63(14):3847-54. PubMed ID: 12873971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell metabolism: cancer's Achilles' heel.
    Kroemer G; Pouyssegur J
    Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose avidity of carcinomas.
    Ortega AD; Sánchez-Aragó M; Giner-Sánchez D; Sánchez-Cenizo L; Willers I; Cuezva JM
    Cancer Lett; 2009 Apr; 276(2):125-35. PubMed ID: 18790562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor metabolome.
    Mazurek S; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):1149-54. PubMed ID: 12820363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.
    Daye D; Wellen KE
    Semin Cell Dev Biol; 2012 Jun; 23(4):362-9. PubMed ID: 22349059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypoxia on tumor metabolism.
    Kim JW; Gao P; Dang CV
    Cancer Metastasis Rev; 2007 Jun; 26(2):291-8. PubMed ID: 17415528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy.
    Scatena R; Bottoni P; Pontoglio A; Giardina B
    Proteomics Clin Appl; 2010 Feb; 4(2):143-58. PubMed ID: 21137040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular adaptation and cancerogenesis].
    La Torre F; Silpigni A; Tomasello R; Picone GS; La Torre I; Aragona M
    Minerva Med; 1998 Jun; 89(6):229-39. PubMed ID: 9739355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
    Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
    J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving concept of tumor microenvironments.
    Laconi E
    Bioessays; 2007 Aug; 29(8):738-44. PubMed ID: 17621638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic microenvironment of tumor cells: a key factor in malignant progression.
    Vaupel P
    Exp Oncol; 2010 Sep; 32(3):125-7. PubMed ID: 21403604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms.
    Liu Y; Zhang W; Cao Y; Liu Y; Bergmeier S; Chen X
    Cancer Lett; 2010 Dec; 298(2):176-85. PubMed ID: 20678861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding an "Achilles' heel" of cancer: the role of glucose and glutamine metabolism in the survival of transformed cells.
    Yuneva M
    Cell Cycle; 2008 Jul; 7(14):2083-9. PubMed ID: 18635953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis.
    Barger JF; Plas DR
    Endocr Relat Cancer; 2010 Dec; 17(4):R287-304. PubMed ID: 20699334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological consequences of tumor hypoxia.
    Höckel M; Vaupel P
    Semin Oncol; 2001 Apr; 28(2 Suppl 8):36-41. PubMed ID: 11395851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do cancer cells acquire the fuel needed to support cell growth?
    Thompson CB; Bauer DE; Lum JJ; Hatzivassiliou G; Zong WX; Zhao F; Ditsworth D; Buzzai M; Lindsten T
    Cold Spring Harb Symp Quant Biol; 2005; 70():357-62. PubMed ID: 16869772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and tumor metabolic reprogramming.
    López-Sánchez LM; Aranda E; Rodríguez-Ariza A
    Biochem Pharmacol; 2020 Jun; 176():113769. PubMed ID: 31862448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proliferative response of hela cells to 2-deoxy-D-glucose under hypoxic or anoxic conditions: an analogue for studying some properties of in vivo solid cancers.
    Anderson KM; Tsui P; Guinan P; Rubenstein M
    Anticancer Res; 2006; 26(6B):4155-62. PubMed ID: 17201127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.